新一轮医改启动以来,我国的基本药物制度已走过7年历程,目前已覆盖全国所有政府办基层医疗卫生机构以及绝大部分村卫生室。然而,在目前各地对基本药物目录进行大幅增补,全面取消药品加成逐步推开,公立医疗机构补偿机制尚未调整到位的大背景下,人们不禁思考:基本药物制度能否承担控制 Since the start of the new round of medical reform, China’s basic medicine system has gone through a seven-year history and has now covered all the government-run primary health care institutions in the country and the vast majority of village clinics. However, at present, under the backdrop of a substantial increase in the list of essential medicines, the gradual elimination of drug additions and the fact that compensation mechanisms for public medical institutions have not been adjusted yet, one can not help thinking: can the basic medicine system take over control?